APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

ADC Drug

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global ADC Drug Market Outlook and Growth Opportunities 2026

Report ID 173960500422 December 2025191 pages

Choose your research edition.

Industry ResearchADC Drug Industry Research Report 2026122 pages · $2,950 USDIndustry Growth & TrendsGlobal ADC Drug Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal ADC Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032183 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal ADC Drug Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal ADC Drug Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global ADC Drug market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for ADC Drug is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the ADC Drug market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the ADC Drug market include RemeGen Co., Ltd., Roche, Gilead(Immunomedics), Pfizer Inc., AstraZeneca, Seagen, Rakuten Medical and ADC Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global ADC Drug market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of ADC Drug and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents ADC Drug sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the ADC Drug market size, projected growth trends, production technologies, key applications, and end-use industries.

ADC Drug Segment by Company

RemeGen Co., Ltd.

Roche

Gilead(Immunomedics)

Pfizer Inc.

AstraZeneca

Seagen

Rakuten Medical

ADC Therapeutics

ADC Drug Segment by Type

First Generation ADC Drug

Third Generation ADC Drug

Second Generation ADC Drug

ADC Drug Segment by Application

Leukemia

Lymphoma

Breast Cancer

Other

ADC Drug Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global ADC Drug status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions ADC Drug market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify ADC Drug significant trends, drivers, influence factors in global and regions.

6. To analyze ADC Drug competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global ADC Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of ADC Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of ADC Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the ADC Drug market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global ADC Drug industry.

Chapter 3: Detailed analysis of ADC Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of ADC Drug in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of ADC Drug in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. ADC Drug Industry Trends Table 2. ADC Drug Industry Drivers Table 3. ADC Drug Industry Opportunities and Challenges Table 4. ADC Drug Industry Restraints Table 5. Global ADC Drug Revenue by Company (US$ Million) & (2021-2026) Table 6. Global ADC Drug Revenue Share by Company (2021-2026) Table 7. Global ADC Drug Sales Volume by Company (k units) & (2021-2026) Table 8. Global ADC Drug Sales Volume Share by Company (2021-2026) Table 9. Global ADC Drug Average Price (US$/unit) of Company (2021-2026) Table 10. Global ADC Drug Company Ranking, (2024-2026) & (USD Million) Table 11. Global ADC Drug Key Company Manufacturing Base & Headquarters Table 12. Global ADC Drug Company, Product Type & Application Table 13. Global ADC Drug Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global ADC Drug by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of First Generation ADC Drug Table 18. Significant Companies of Third Generation ADC Drug Table 19. Significant Companies of Second Generation ADC Drug Table 20. Global ADC Drug Sales Volume by Type 2021 VS 2025 VS 2032 (k units) Table 21. Global ADC Drug Sales Volume by Type (2021-2026) & (k units) Table 22. Global ADC Drug Sales Volume by Type (2027-2032) & (k units) Table 23. Global ADC Drug Sales Volume Share by Type (2021-2026) Table 24. Global ADC Drug Sales Volume Share by Type (2027-2032) Table 25. Global ADC Drug Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global ADC Drug Sales Value by Type (2021-2026) & (US$ Million) Table 27. Global ADC Drug Sales Value by Type (2027-2032) & (US$ Million) Table 28. Global ADC Drug Sales Value Share by Type (2021-2026) Table 29. Global ADC Drug Sales Value Share by Type (2027-2032) Table 30. Significant Companies of Leukemia Table 31. Significant Companies of Lymphoma Table 32. Significant Companies of Breast Cancer Table 33. Significant Companies of Other Table 34. Global ADC Drug Sales Volume by Application 2021 VS 2025 VS 2032 (k units) Table 35. Global ADC Drug Sales Volume by Application (2021-2026) & (k units) Table 36. Global ADC Drug Sales Volume by Application (2027-2032) & (k units) Table 37. Global ADC Drug Sales Volume Share by Application (2021-2026) Table 38. Global ADC Drug Sales Volume Share by Application (2027-2032) Table 39. Global ADC Drug Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global ADC Drug Sales Value by Application (2021-2026) & (US$ Million) Table 41. Global ADC Drug Sales Value by Application (2027-2032) & (US$ Million) Table 42. Global ADC Drug Sales Value Share by Application (2021-2026) Table 43. Global ADC Drug Sales Value Share by Application (2027-2032) Table 44. Global ADC Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 45. Global ADC Drug Sales by Region (2021-2026) & (k units) Table 46. Global ADC Drug Sales Market Share by Region (2021-2026) Table 47. Global ADC Drug Sales by Region (2027-2032) & (k units) Table 48. Global ADC Drug Sales Market Share by Region (2027-2032) Table 49. Global ADC Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global ADC Drug Sales Value by Region (2021-2026) & (US$ Million) Table 51. Global ADC Drug Sales Value Share by Region (2021-2026) Table 52. Global ADC Drug Sales Value by Region (2027-2032) & (US$ Million) Table 53. Global ADC Drug Sales Value Share by Region (2027-2032) Table 54. Global ADC Drug Market Average Price (US$/unit) by Region (2021-2026) Table 55. Global ADC Drug Market Average Price (US$/unit) by Region (2027-2032) Table 56. Global ADC Drug Sales by Country: 2021 VS 2025 VS 2032 (k units) Table 57. Global ADC Drug Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 58. Global ADC Drug Sales by Country (2021-2026) & (k units) Table 59. Global ADC Drug Sales Market Share by Country (2021-2026) Table 60. Global ADC Drug Sales by Country (2027-2032) & (k units) Table 61. Global ADC Drug Sales Market Share by Country (2027-2032) Table 62. Global ADC Drug Sales Value by Country (2021-2026) & (US$ Million) Table 63. Global ADC Drug Sales Value Market Share by Country (2021-2026) Table 64. Global ADC Drug Sales Value by Country (2027-2032) & (US$ Million) Table 65. Global ADC Drug Sales Value Market Share by Country (2027-2032) Table 66. RemeGen Co., Ltd. Company Information Table 67. RemeGen Co., Ltd. Business Overview Table 68. RemeGen Co., Ltd. ADC Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. RemeGen Co., Ltd. ADC Drug Product Portfolio Table 70. RemeGen Co., Ltd. Recent Development Table 71. Roche Company Information Table 72. Roche Business Overview Table 73. Roche ADC Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Roche ADC Drug Product Portfolio Table 75. Roche Recent Development Table 76. Gilead(Immunomedics) Company Information Table 77. Gilead(Immunomedics) Business Overview Table 78. Gilead(Immunomedics) ADC Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Gilead(Immunomedics) ADC Drug Product Portfolio Table 80. Gilead(Immunomedics) Recent Development Table 81. Pfizer Inc. Company Information Table 82. Pfizer Inc. Business Overview Table 83. Pfizer Inc. ADC Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Pfizer Inc. ADC Drug Product Portfolio Table 85. Pfizer Inc. Recent Development Table 86. AstraZeneca Company Information Table 87. AstraZeneca Business Overview Table 88. AstraZeneca ADC Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. AstraZeneca ADC Drug Product Portfolio Table 90. AstraZeneca Recent Development Table 91. Seagen Company Information Table 92. Seagen Business Overview Table 93. Seagen ADC Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Seagen ADC Drug Product Portfolio Table 95. Seagen Recent Development Table 96. Rakuten Medical Company Information Table 97. Rakuten Medical Business Overview Table 98. Rakuten Medical ADC Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Rakuten Medical ADC Drug Product Portfolio Table 100. Rakuten Medical Recent Development Table 101. ADC Therapeutics Company Information Table 102. ADC Therapeutics Business Overview Table 103. ADC Therapeutics ADC Drug Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. ADC Therapeutics ADC Drug Product Portfolio Table 105. ADC Therapeutics Recent Development Table 106. Key Raw Materials Table 107. Raw Materials Key Suppliers Table 108. ADC Drug Distributors List Table 109. ADC Drug Customers List Table 110. Research Programs/Design for This Report Table 111. Authors List of This Report Table 112. Secondary Sources Table 113. Primary Sources List of Figures Figure 1. ADC Drug Product Image Figure 2. Global ADC Drug Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 4. Global ADC Drug Sales (2021-2032) & (k units) Figure 5. Global ADC Drug Sales Average Price (US$/unit) & (2021-2032) Figure 6. Global ADC Drug Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. First Generation ADC Drug Image Figure 10. Third Generation ADC Drug Image Figure 11. Second Generation ADC Drug Image Figure 12. Global ADC Drug Sales Volume by Type (2021 VS 2025 VS 2032) & (k units) Figure 13. Global ADC Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 14. Global ADC Drug Sales Volume Share by Type (2021-2032) Figure 15. Global ADC Drug Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 16. Global ADC Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 17. Global ADC Drug Sales Value Share by Type (2021-2032) Figure 18. Leukemia Image Figure 19. Lymphoma Image Figure 20. Breast Cancer Image Figure 21. Other Image Figure 22. Global ADC Drug Sales Volume by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global ADC Drug Sales Volume Share 2021 VS 2025 VS 2032 Figure 24. Global ADC Drug Sales Volume Share by Application (2021-2032) Figure 25. Global ADC Drug Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 26. Global ADC Drug Sales Value Share 2021 VS 2025 VS 2032 Figure 27. Global ADC Drug Sales Value Share by Application (2021-2032) Figure 28. Global ADC Drug Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 29. Global ADC Drug Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 30. Global ADC Drug Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 31. Global ADC Drug Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 32. North America ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 33. North America ADC Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Europe ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 35. Europe ADC Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 36. Asia-Pacific ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 37. Asia-Pacific ADC Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 38. South America ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 39. South America ADC Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 40. Middle East & Africa ADC Drug Sales Value (2021-2032) & (US$ Million) Figure 41. Middle East & Africa ADC Drug Sales Value Share by Country (%), 2025 VS 2032 Figure 42. USA ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 43. USA ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 44. USA ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 45. Canada ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 46. Canada ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 47. Canada ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 48. Mexico ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 49. Mexico ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 50. Mexico ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 51. Germany ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 52. Germany ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 53. Germany ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 54. France ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 55. France ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 56. France ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 57. U.K. ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 58. U.K. ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 59. U.K. ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 60. Italy ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 61. Italy ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 62. Italy ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 63. Spain ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 64. Spain ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 65. Spain ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 66. Russia ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 67. Russia ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 68. Russia ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 69. Netherlands ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 70. Netherlands ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 71. Netherlands ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 72. Nordic Countries ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 73. Nordic Countries ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 74. Nordic Countries ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 75. China ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 76. China ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 77. China ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 78. Japan ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 79. Japan ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 80. Japan ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 81. South Korea ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 82. South Korea ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 83. South Korea ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 84. India ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 85. India ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 86. India ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 87. Australia ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 88. Australia ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 89. Australia ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 90. Southeast Asia ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 91. Southeast Asia ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 92. Southeast Asia ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 93. Brazil ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 94. Brazil ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 95. Brazil ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 96. Argentina ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 97. Argentina ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 98. Argentina ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 99. Chile ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 100. Chile ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 101. Chile ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 102. Colombia ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 103. Colombia ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 104. Colombia ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 105. Peru ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 106. Peru ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 107. Peru ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 108. Saudi Arabia ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 109. Saudi Arabia ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 110. Saudi Arabia ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 111. Israel ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 112. Israel Arabia ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 113. Israel Arabia ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 114. UAE ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 115. UAE ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 116. UAE ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 117. Turkey ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 118. Turkey ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 119. Turkey ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 120. Iran ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 121. Iran ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 122. Iran ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 123. Egypt ADC Drug Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 124. Egypt ADC Drug Sales Value Share by Type, 2025 VS 2032 & (%) Figure 125. Egypt ADC Drug Sales Value Share by Application, 2025 VS 2032 & (%) Figure 126. ADC Drug Value Chain Figure 127. Manufacturing Cost Structure Figure 128. ADC Drug Sales Mode & Process Figure 129. Direct Comparison with Distribution Share Figure 130. Distributors Profiles Figure 131. Years Considered Figure 132. Research Process Figure 133. Key Executives Interviewed

Scope & coverage.

Types
  • First Generation ADC Drug
  • Third Generation ADC Drug
  • Second Generation ADC Drug
Applications
  • Leukemia
  • Lymphoma
  • Breast Cancer
  • Other
Companies covered
  • RemeGen Co., Ltd.
  • Roche
  • Gilead(Immunomedics)
  • Pfizer Inc.
  • AstraZeneca
  • Seagen
  • Rakuten Medical
  • ADC Therapeutics

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global ADC Drug Sales Value (2021-2032)
  4. 1.2.2 Global ADC Drug Sales Volume (2021-2032)
  5. 1.2.3 Global ADC Drug Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 ADC Drug Market Dynamics
  1. 2.1 ADC Drug Industry Trends
  2. 2.2 ADC Drug Industry Drivers
  3. 2.3 ADC Drug Industry Opportunities and Challenges
  4. 2.4 ADC Drug Industry Restraints
3 ADC Drug Market by Company
  1. 3.1 Global ADC Drug Company Revenue Ranking in 2025
  2. 3.2 Global ADC Drug Revenue by Company (2021-2026)
  3. 3.3 Global ADC Drug Sales Volume by Company (2021-2026)
  4. 3.4 Global ADC Drug Average Price by Company (2021-2026)
  5. 3.5 Global ADC Drug Company Ranking (2024-2026)
  6. 3.6 Global ADC Drug Company Manufacturing Base and Headquarters
  7. 3.7 Global ADC Drug Company Product Type and Application
  8. 3.8 Global ADC Drug Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global ADC Drug Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 ADC Drug Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 ADC Drug Market by Type
  1. 4.1 ADC Drug Type Introduction
  2. 4.1.1 First Generation ADC Drug
  3. 4.1.2 Third Generation ADC Drug
  4. 4.1.3 Second Generation ADC Drug
  5. 4.2 Global ADC Drug Sales Volume by Type
  6. 4.2.1 Global ADC Drug Sales Volume by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global ADC Drug Sales Volume by Type (2021-2032)
  8. 4.2.3 Global ADC Drug Sales Volume Share by Type (2021-2032)
  9. 4.3 Global ADC Drug Sales Value by Type
  10. 4.3.1 Global ADC Drug Sales Value by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global ADC Drug Sales Value by Type (2021-2032)
  12. 4.3.3 Global ADC Drug Sales Value Share by Type (2021-2032)
5 ADC Drug Market by Application
  1. 5.1 ADC Drug Application Introduction
  2. 5.1.1 Leukemia
  3. 5.1.2 Lymphoma
  4. 5.1.3 Breast Cancer
  5. 5.1.4 Other
  6. 5.2 Global ADC Drug Sales Volume by Application
  7. 5.2.1 Global ADC Drug Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global ADC Drug Sales Volume by Application (2021-2032)
  9. 5.2.3 Global ADC Drug Sales Volume Share by Application (2021-2032)
  10. 5.3 Global ADC Drug Sales Value by Application
  11. 5.3.1 Global ADC Drug Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global ADC Drug Sales Value by Application (2021-2032)
  13. 5.3.3 Global ADC Drug Sales Value Share by Application (2021-2032)
6 ADC Drug Regional Sales and Value Analysis
  1. 6.1 Global ADC Drug Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global ADC Drug Sales by Region (2021-2032)
  3. 6.2.1 Global ADC Drug Sales by Region: 2021-2026
  4. 6.2.2 Global ADC Drug Sales by Region (2027-2032)
  5. 6.3 Global ADC Drug Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global ADC Drug Sales Value by Region (2021-2032)
  7. 6.4.1 Global ADC Drug Sales Value by Region: 2021-2026
  8. 6.4.2 Global ADC Drug Sales Value by Region (2027-2032)
  9. 6.5 Global ADC Drug Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America ADC Drug Sales Value (2021-2032)
  12. 6.6.2 North America ADC Drug Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe ADC Drug Sales Value (2021-2032)
  15. 6.7.2 Europe ADC Drug Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific ADC Drug Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific ADC Drug Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America ADC Drug Sales Value (2021-2032)
  21. 6.9.2 South America ADC Drug Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa ADC Drug Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa ADC Drug Sales Value Share by Country, 2025 VS 2032
7 ADC Drug Country-level Sales and Value Analysis
  1. 7.1 Global ADC Drug Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global ADC Drug Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global ADC Drug Sales by Country (2021-2032)
  4. 7.3.1 Global ADC Drug Sales by Country (2021-2026)
  5. 7.3.2 Global ADC Drug Sales by Country (2027-2032)
  6. 7.4 Global ADC Drug Sales Value by Country (2021-2032)
  7. 7.4.1 Global ADC Drug Sales Value by Country (2021-2026)
  8. 7.4.2 Global ADC Drug Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA ADC Drug Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA ADC Drug Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA ADC Drug Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada ADC Drug Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada ADC Drug Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada ADC Drug Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico ADC Drug Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico ADC Drug Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico ADC Drug Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany ADC Drug Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany ADC Drug Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany ADC Drug Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France ADC Drug Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France ADC Drug Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France ADC Drug Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. ADC Drug Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. ADC Drug Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. ADC Drug Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy ADC Drug Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy ADC Drug Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy ADC Drug Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain ADC Drug Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain ADC Drug Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain ADC Drug Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia ADC Drug Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia ADC Drug Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia ADC Drug Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands ADC Drug Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands ADC Drug Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands ADC Drug Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries ADC Drug Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries ADC Drug Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries ADC Drug Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China ADC Drug Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China ADC Drug Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China ADC Drug Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan ADC Drug Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan ADC Drug Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan ADC Drug Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea ADC Drug Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea ADC Drug Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea ADC Drug Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India ADC Drug Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India ADC Drug Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India ADC Drug Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia ADC Drug Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia ADC Drug Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia ADC Drug Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia ADC Drug Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia ADC Drug Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia ADC Drug Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil ADC Drug Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil ADC Drug Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil ADC Drug Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina ADC Drug Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina ADC Drug Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina ADC Drug Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile ADC Drug Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile ADC Drug Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile ADC Drug Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia ADC Drug Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia ADC Drug Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia ADC Drug Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru ADC Drug Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru ADC Drug Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru ADC Drug Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia ADC Drug Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia ADC Drug Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia ADC Drug Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel ADC Drug Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel ADC Drug Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel ADC Drug Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE ADC Drug Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE ADC Drug Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE ADC Drug Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey ADC Drug Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey ADC Drug Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey ADC Drug Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran ADC Drug Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran ADC Drug Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran ADC Drug Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt ADC Drug Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt ADC Drug Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt ADC Drug Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 RemeGen Co., Ltd.
  2. 8.1.1 RemeGen Co., Ltd. Company Information
  3. 8.1.2 RemeGen Co., Ltd. Business Overview
  4. 8.1.3 RemeGen Co., Ltd. ADC Drug Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 RemeGen Co., Ltd. ADC Drug Product Portfolio
  6. 8.1.5 RemeGen Co., Ltd. Recent Developments
  7. 8.2 Roche
  8. 8.2.1 Roche Company Information
  9. 8.2.2 Roche Business Overview
  10. 8.2.3 Roche ADC Drug Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Roche ADC Drug Product Portfolio
  12. 8.2.5 Roche Recent Developments
  13. 8.3 Gilead(Immunomedics)
  14. 8.3.1 Gilead(Immunomedics) Company Information
  15. 8.3.2 Gilead(Immunomedics) Business Overview
  16. 8.3.3 Gilead(Immunomedics) ADC Drug Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Gilead(Immunomedics) ADC Drug Product Portfolio
  18. 8.3.5 Gilead(Immunomedics) Recent Developments
  19. 8.4 Pfizer Inc.
  20. 8.4.1 Pfizer Inc. Company Information
  21. 8.4.2 Pfizer Inc. Business Overview
  22. 8.4.3 Pfizer Inc. ADC Drug Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Pfizer Inc. ADC Drug Product Portfolio
  24. 8.4.5 Pfizer Inc. Recent Developments
  25. 8.5 AstraZeneca
  26. 8.5.1 AstraZeneca Company Information
  27. 8.5.2 AstraZeneca Business Overview
  28. 8.5.3 AstraZeneca ADC Drug Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 AstraZeneca ADC Drug Product Portfolio
  30. 8.5.5 AstraZeneca Recent Developments
  31. 8.6 Seagen
  32. 8.6.1 Seagen Company Information
  33. 8.6.2 Seagen Business Overview
  34. 8.6.3 Seagen ADC Drug Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Seagen ADC Drug Product Portfolio
  36. 8.6.5 Seagen Recent Developments
  37. 8.7 Rakuten Medical
  38. 8.7.1 Rakuten Medical Company Information
  39. 8.7.2 Rakuten Medical Business Overview
  40. 8.7.3 Rakuten Medical ADC Drug Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Rakuten Medical ADC Drug Product Portfolio
  42. 8.7.5 Rakuten Medical Recent Developments
  43. 8.8 ADC Therapeutics
  44. 8.8.1 ADC Therapeutics Company Information
  45. 8.8.2 ADC Therapeutics Business Overview
  46. 8.8.3 ADC Therapeutics ADC Drug Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 ADC Therapeutics ADC Drug Product Portfolio
  48. 8.8.5 ADC Therapeutics Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 ADC Drug Value Chain Analysis
  2. 9.1.1 ADC Drug Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 ADC Drug Sales Mode & Process
  6. 9.2 ADC Drug Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 ADC Drug Distributors
  9. 9.2.3 ADC Drug Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst